메타바이오메드: management transactions · South Korea · DART (FSS)

Browse the full directors' dealings record of 메타바이오메드, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Market capitalisation: €133.3bn. The latest transaction was disclosed on 27 April 2026 — Purchase. Among the most active insiders: 오지수. Every trade is accessible without an account.